in a subsequent clinical study using 123i-labelled monoclonal antibodies in 10 patients with ovarian cancer , tumor detection was achieved in 8 patients , with tumor uptake of labelled antibody ranging between 0.2-2.6 % .
C0003250
monoclonal antibodies
C0003241
antibody